MELE, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.933
AS - Asia 1.695
EU - Europa 1.600
SA - Sud America 456
Continente sconosciuto - Info sul continente non disponibili 231
AF - Africa 86
OC - Oceania 5
Totale 9.006
Nazione #
US - Stati Uniti d'America 4.768
IT - Italia 640
SG - Singapore 629
CN - Cina 422
BR - Brasile 358
HK - Hong Kong 180
SE - Svezia 179
RU - Federazione Russa 177
VN - Vietnam 125
DE - Germania 122
FR - Francia 104
GB - Regno Unito 91
FI - Finlandia 85
CA - Canada 75
BD - Bangladesh 73
IN - India 58
UA - Ucraina 57
ID - Indonesia 35
IQ - Iraq 33
MX - Messico 26
AR - Argentina 25
CI - Costa d'Avorio 24
ES - Italia 22
NL - Olanda 22
PL - Polonia 22
ZA - Sudafrica 22
BE - Belgio 19
CO - Colombia 19
EC - Ecuador 18
JP - Giappone 18
CR - Costa Rica 15
PK - Pakistan 15
TR - Turchia 14
CZ - Repubblica Ceca 11
IL - Israele 11
UZ - Uzbekistan 10
VE - Venezuela 10
CL - Cile 9
MY - Malesia 9
RS - Serbia 9
GP - Guadalupe 8
JO - Giordania 8
AT - Austria 7
IE - Irlanda 7
KZ - Kazakistan 7
PH - Filippine 7
SA - Arabia Saudita 7
UY - Uruguay 7
GT - Guatemala 6
HN - Honduras 6
LT - Lituania 6
MA - Marocco 6
SV - El Salvador 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
AU - Australia 5
EG - Egitto 5
KE - Kenya 5
NI - Nicaragua 5
OM - Oman 5
PE - Perù 5
SN - Senegal 5
TN - Tunisia 5
DZ - Algeria 4
PR - Porto Rico 4
AE - Emirati Arabi Uniti 3
PA - Panama 3
RO - Romania 3
SC - Seychelles 3
A1 - Anonimo 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
Totale 8.769
Città #
Ashburn 577
Fairfield 418
Singapore 332
Woodbridge 317
Chandler 295
San Jose 289
Ann Arbor 206
Dallas 203
Hong Kong 178
Milan 178
Houston 176
Seattle 169
Wilmington 158
Beijing 152
Cambridge 152
Nyköping 152
Jacksonville 124
Council Bluffs 108
Bari 101
Los Angeles 78
Rome 66
Lauterbourg 56
New York 54
Santa Clara 54
Lawrence 53
Roxbury 53
Nanjing 51
Ho Chi Minh City 45
Boardman 40
Des Moines 40
Helsinki 38
São Paulo 36
Inglewood 30
Princeton 27
San Diego 26
Abidjan 24
Buffalo 23
Jakarta 22
Chicago 21
London 21
Munich 20
Brussels 19
Montreal 19
Toronto 19
Brooklyn 18
Columbus 18
Frankfurt am Main 17
Hanoi 17
Warsaw 17
Atlanta 16
Dong Ket 15
Baghdad 14
Denver 14
Falkenstein 14
Figino 14
Mexico City 14
Rio de Janeiro 14
Tokyo 14
Grottaglie 13
Moscow 13
San Francisco 13
San José 13
Hebei 12
Johannesburg 12
Nanchang 12
North Bergen 12
Chennai 11
Nuremberg 11
Orem 11
Turku 11
York 11
Jiaxing 10
Shenyang 10
Belgrade 9
Belo Horizonte 9
Changsha 9
Da Nang 9
Dhaka 9
Shanghai 9
Brasília 8
Brno 8
Florence 8
Naples 8
Phoenix 8
Quito 8
Stockholm 8
Tianjin 8
Ankara 7
Bogotá 7
Campinas 7
Charlotte 7
Madrid 7
Mumbai 7
Redwood City 7
Tashkent 7
Amman 6
Amsterdam 6
Boston 6
Curitiba 6
Dublin 6
Totale 5.815
Nome #
Utilizzo di safe dose di rTPA nel trattamento dell'embolia polmonare massiva associata ad elevato rischio emorragico: Caso clinico e revisione della letteratura 284
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 267
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 242
A novel injectable formulation of 6-Fluoro-L-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson’s disease 241
In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography 213
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 212
Antiproliferative effects of neuroprotective drugs targeting big Ca2+-activated K+ (BK) channel in the undifferentiated neuroblastoma cells 211
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 210
Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels 204
Acetazolamide prevents vacuolar myopathy in skeletal muscle of K+-depleted rats 204
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 181
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats 172
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 170
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 162
The large conductance Ca2+ -activated K+ (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases 159
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 150
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 150
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 150
Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: Pharmacological perspectives 148
Calcium-Activated K Channel Regulates Cell Viability in Hyperkalemic and Hypokalemic Conditions: Implication in the Neuromuscular Disoders 144
Effects of Acetazolamide on alpha subunit of human BK channel expressed in HEK293 cells 143
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 143
Commentary: A BK (Slo1) channel journey from molecule to physiology. 141
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 139
Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle 138
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 137
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 136
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 136
Atrophy and phenotype transition signaling exert opposite actions on the KATP channels of disused rat soleus muscle 135
Staurosporine Blocks the ATP-Sensitive K+ Channels and Induces Atrophy in Rodent Skeletal Muscles 135
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties 135
Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes 133
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 129
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle 129
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type dependent biophysical and pharmacological properties 127
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 124
Drugs targeting the metabolically regulated ATP-sensitive potassium channels and big calcium-activated potassium channels in skeletal muscles: Pharmacological perspectives and therapeutic use 124
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 124
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 120
Biophysical and pharmacological characterization of K-ATP and BK channels of slow and fast rat skeletal muscle fibers 118
Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II 113
The KATP channel is a molecular sensor of atrophy in skeletal muscle 111
An olive oil–derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 109
Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs. 108
Phenotype-dependent functional and pharmacological properties of BK channels in skeletal muscle: Effects of microgravity 107
Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome 105
Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome 104
Bendroflumethiazide a potent opener of human BK channel : a new perspective for an old drug in the treatment of periodic paralysis 103
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 93
Brugada Syndrome: More than a Monogenic Channelopathy 92
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 91
null 90
Phenotypic-dependent biophysical and pharmacological characteristics of BK channels in skeletal muscle and effects of microgravity 89
The biophysical properties, pharmacological responses and molecular composition of KATP channels in skeletal muscle type specific 83
Phenotypic-dependent biophysical and pharmacological characteristic of BK channels in skeletal muscle and effects of microgravity 82
Expression of sarcolemmal ion channels in slow and fast-twitch muscles of rodents in simulated and actual microgravity 80
The biophysical properties, pharmacological responses and molecular composition of KATP channels in skeletal muscle are muscle type specific 79
Pharmacovigilance-pharmacological investigations on sulfonylureas and glinides-induced atrophy in skeletal muscle 79
null 77
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach 72
null 68
How brachial access compares to femoral access for invasive cardiac angiography when radial access is not feasible: A meta-analysis 65
Meta-regression analysis on the impact of medical therapy on long-term outcome in spontaneous coronary artery dissection 64
Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cell and pharmacological modulation 64
CUPID: A free drug discovery platform for the explainable multi-ion channel assessment of cardiotoxicity 54
Opening/blocking actions of pyruvate kinase antibodies on neuronal and muscular KATP channels 53
null 49
Biomarker profiles that differentiate type-1 and type 2 myocardial infarction 46
Impact of Frailty on Outcome of Older Patients With Non-ST Elevation Acute Myocardial Infarction Who Undergo Percutaneous Coronary Intervention 42
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 39
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 34
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 29
Drug repurposing based on integrated in silico and in vitro approach to find a therapy for KCNA2-related disorders 12
Totale 9.006
Categoria #
all - tutte 35.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022342 0 0 0 0 19 29 21 21 29 39 67 117
2022/2023780 89 96 58 70 87 94 9 83 132 8 30 24
2023/2024327 20 45 20 34 55 58 4 22 3 23 7 36
2024/20251.271 53 25 76 51 44 120 151 147 64 70 158 312
2025/20262.964 366 143 285 276 347 119 293 78 319 271 106 361
2026/2027874 101 132 183 420 38 0 0 0 0 0 0 0
Totale 9.006